Novella Clinical has appointed Dr Chris Smyth as managing director for its European and Asian operations.
Dr Smyth joins the Quintiles-owned contract research organisation from INC Research, where he most recently served as senior vice president of clinical development in that CRO’s oncology division.
He has more than 20 years research and development experience in the pharmaceutical industry, during which time he has led CROs and biopharmaceutical companies in both Europe and the US.
Novella Clinical’s chief operating officer Rob King said: “We are fortunate to have someone as experienced as Dr Smyth guiding our team and business objectives in Europe and Asia.
“His depth of international leadership and oncology operations expertise will prove to be an invaluable resource as we continue to expand our services into new markets.”
In his new role Dr Smyth will be based in Novella’s European headquarters in Stevenage, England and he succeeds Elizabeth Edwards, who will now serve as executive vice president of global operations, overseeing Novella’s clinical monitoring division.